# |
PMID |
Sentence |
1 |
28316372
|
The expression of genes, including IL10, JAK1, STAT3, SOCS3, IP10, ICAM1, IFNA, IFNG, STAT1, and IRF1, was investigated by RT-qPCR.
|
2 |
28316372
|
The expression of genes, including IL10, JAK1, STAT3, SOCS3, IP10, ICAM1, IFNA, IFNG, STAT1, and IRF1, was investigated by RT-qPCR.
|
3 |
28316372
|
Patients with dyslipidemia demonstrated statistically higher expression of the IL10 and IFNA genes, while IFNG, IP10, IRF1, JAK1, and STAT3 were lower in comparison with nondyslipidemic patients.
|
4 |
28316372
|
Patients with dyslipidemia demonstrated statistically higher expression of the IL10 and IFNA genes, while IFNG, IP10, IRF1, JAK1, and STAT3 were lower in comparison with nondyslipidemic patients.
|
5 |
25346938
|
Depression is a common side-effect of interferon (IFN)-alpha treatment of hepatitis C virus (HCV) infection and melanoma.
|
6 |
25346938
|
Depression is a common side-effect of interferon (IFN)-alpha treatment of hepatitis C virus (HCV) infection and melanoma.
|
7 |
25346938
|
Depression is a common side-effect of interferon (IFN)-alpha treatment of hepatitis C virus (HCV) infection and melanoma.
|
8 |
25346938
|
Depression is a common side-effect of interferon (IFN)-alpha treatment of hepatitis C virus (HCV) infection and melanoma.
|
9 |
25346938
|
Disturbances of tryptophan (TRP) metabolism might contribute to development of IFN-alpha-associated depression due to IFN-alpha-induced activation of indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme of TRP-kynurenine (KYN) metabolism.
|
10 |
25346938
|
Disturbances of tryptophan (TRP) metabolism might contribute to development of IFN-alpha-associated depression due to IFN-alpha-induced activation of indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme of TRP-kynurenine (KYN) metabolism.
|
11 |
25346938
|
Disturbances of tryptophan (TRP) metabolism might contribute to development of IFN-alpha-associated depression due to IFN-alpha-induced activation of indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme of TRP-kynurenine (KYN) metabolism.
|
12 |
25346938
|
Disturbances of tryptophan (TRP) metabolism might contribute to development of IFN-alpha-associated depression due to IFN-alpha-induced activation of indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme of TRP-kynurenine (KYN) metabolism.
|
13 |
25346938
|
The present study assessed KYN/TRP ratio (KTR) as a marker of IDO activity in American Caucasian HCV patients awaiting IFN-alpha treatment.
|
14 |
25346938
|
The present study assessed KYN/TRP ratio (KTR) as a marker of IDO activity in American Caucasian HCV patients awaiting IFN-alpha treatment.
|
15 |
25346938
|
The present study assessed KYN/TRP ratio (KTR) as a marker of IDO activity in American Caucasian HCV patients awaiting IFN-alpha treatment.
|
16 |
25346938
|
The present study assessed KYN/TRP ratio (KTR) as a marker of IDO activity in American Caucasian HCV patients awaiting IFN-alpha treatment.
|
17 |
25346938
|
Up-regulation of IDO might be an additional risk factor of IFN-alpha-associated depression.
|
18 |
25346938
|
Up-regulation of IDO might be an additional risk factor of IFN-alpha-associated depression.
|
19 |
25346938
|
Up-regulation of IDO might be an additional risk factor of IFN-alpha-associated depression.
|
20 |
25346938
|
Up-regulation of IDO might be an additional risk factor of IFN-alpha-associated depression.
|
21 |
25346938
|
Future studies shall explore the causes of elevated serum TRP in relation to IFN-alpha-associated depression.
|
22 |
25346938
|
Future studies shall explore the causes of elevated serum TRP in relation to IFN-alpha-associated depression.
|
23 |
25346938
|
Future studies shall explore the causes of elevated serum TRP in relation to IFN-alpha-associated depression.
|
24 |
25346938
|
Future studies shall explore the causes of elevated serum TRP in relation to IFN-alpha-associated depression.
|
25 |
20376717
|
In the past we have analysed candidate genes and their role in the course of malaria and could detect some polymorphisms influencing infectious diseases in the genes encoding NOS2, MBL2, IFNa, FCN2, and receptors for IFNg and IFNa.
|